NESS ZIONA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting ...

Fuel injectors rarely get the same attention as turbochargers, superchargers, or cylinder heads, but they play a far more critical role than most enthusiasts realize. Every fuel-injected engine, ...

The investment was made through Merak Capital’s Gaming Fund, backed by the National Development Fund. Khosouf aims to contribute to Saudi Arabia’s Vision 2030 push to become a global game development ...

350 is building a future that's just, prosperous, equitable and safe from the effects of the climate crisis. We're an international movement of ordinary people working to end the age of fossil fuels ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...

The recent closure of a California oil refinery — and plans to shutter another in the near future — have some experts warning of potential fuel shortages and price spikes in Nevada and other Western ...

Colombia and the Netherlands have announced plans to co-host the world’s first international conference focused exclusively on transitioning away from fossil fuels. The landmark summit will take place ...

Electronic fuel injection revolutionized the auto industry in the 1980s. It came to replace the carburetor in the task of sending fuel to the engine's cylinders but it does much more: it controls ...

The Trade Desk TTD is entering its next phase of expansion with a financial profile that underscores capacity for long-term investment. TTD had a strong balance sheet at the end of the third quarter, ...

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

A phase 3 trial of Belite Bio’s tinlarebant in adolescents with a rare genetic eye disease has met its primary endpoint, encouraging the biotech to add the U.S. to the list of countries in which it ...